Before you read further — leave now if:
- →You take progesterone for IVF, fertility treatment, or pregnancy support. Different protocol. Contact your clinic immediately. Nothing here applies.
- →You mean a progestin-only birth control pill. Missed-pill rules there affect pregnancy protection. Use your pill's own instructions.
- →You take progesterone as part of gender-affirming care. Different goals, different combinations. Ask your prescriber.
- ⚠You have emergency symptoms — collapse, seizure, trouble breathing, chest pain, sudden weakness or trouble speaking. Call 911 now.
- ⚠You took much more than prescribed. US Poison Control: 1-800-222-1222 or poison.org. Don't guess.
We'd rather lose you in ten seconds than hand you the wrong answer.
Start here: the 20-second version
| Your situation | What to do |
|---|---|
| One known miss, you know your product | Find that product's own instruction in the audit table below and follow it |
| Not sure whether you took it | Don't take an extra one to settle it. Check your pack. Still unsure? Ask a pharmacist. |
| Two or more misses, or a missed phase | Contact your pharmacist or prescriber. Sooner if you're bleeding. |
| Spotting or bleeding | Follow your product's instruction and report the bleeding. Use the urgent pathway below if it's heavy. |
| Extra dose, or unknown amount taken | US: Poison Control 1-800-222-1222. Emergency symptoms: 911. |
Missed progesterone dose HRT: what do I do right now?
Find the exact product name on your bottle, then follow that product's own missed-dose instruction. For oral progesterone, MedlinePlus directs taking the missed dose when remembered unless it's almost time for the next dose, then skipping it — and never doubling. Products differ, so the rule that applies to you is the one printed for what you actually take.
That sounds like a dodge. It isn't. It's the finding. Keep reading and you'll see why it's the only honest answer — and why it's more useful than the confident-sounding rules elsewhere.
Step one: identify what you actually take
Look at the bottle. Right now. You need:
- The exact brand or product name — Prometrium? generic progesterone? Bijuva? Prempro? Utrogestan?
- The active ingredients — progesterone? medroxyprogesterone? norethindrone? estradiol and a progestogen?
- The strength — 100 mg? 200 mg?
- The route — capsule, tablet, patch, vaginal?
- The country it was dispensed in — US and UK instructions genuinely differ
- The schedule — daily, or only certain days?
- The last dose you're certain you took, and when the next one is due
Every reliable answer to your question depends on those seven things. If the bottle doesn't say, your pharmacy app or patient portal will.
If you take progesterone every day (continuous)
A continuous regimen means progesterone every day alongside estrogen, with no scheduled break. For standalone oral micronized progesterone, the current US consumer instruction from MedlinePlus (revised April 15, 2026) is: take it when you remember; if it's almost time for the next dose, skip it; don't double.
Note what that instruction does notcontain: a number. “Almost time” is the actual, official, current wording — and we're not going to invent a number where the source declines to give one.
If you take it 12 to 14 days per cycle (sequential or cyclical)
Common in perimenopause: estrogen daily, progesterone only part of the month. Follow your product's missed-dose instruction — same as above. Then this, which matters:
If your progesterone is inside a combination pill
Bijuva, Prempro, Premphase and similar products contain both hormones in one pill. You can't miss one without missing the other. These have their own rules, and they're not the same as each other. See the audit table below — it's the reason this page exists.
If you use vaginal progesterone
Follow your prescriber's exact plan. Don't substitute oral rules. Worth knowing: vaginal progesterone for endometrial protection is off-label in the United States, and the evidence is regimen-specific. The British Menopause Society reports that some studied vaginal regimens may provide protection, while in the ELITE trial a lower-dose regimen produced significantly more endometrial thickening and a substantially higher hyperplasia rate than expected on that protocol. Ask your prescriber what yours is based on.
If you have a Mirena or another levonorgestrel IUD
There's no daily dose to miss. The device releases hormone continuously.
BMS guidance supports the 52 mg levonorgestrel IUD for endometrial protection within HRT for up to five years. In the United States, Mirena is not FDA-approved for menopausal-HRT endometrial protection— its US approvals cover contraception and heavy menstrual bleeding. That's a real distinction worth knowing, not a reason for alarm.
Lower-dose IUDs are not the same.BMS says evidence is insufficient for the 13.5 mg and 19.5 mg devices as the sole progestogen in HRT. If you're not sure which one you have, that's worth a call.
Is one missed progesterone dose dangerous?
No study we found measures the endometrial risk of a single missed dose. What the evidence does measure is long-term exposure: unopposed estrogen raises hyperplasia risk in a dose- and duration-dependent way across one to three years. Official instructions treat one known miss as a routine take-or-skip decision, not an emergency.
That's the honest answer, and we think it's better than the false comfort you'll find elsewhere.
What the evidence answers — and what it doesn't
| Question | Status |
|---|---|
| Does long-term prescribed progestogen reduce hyperplasia from estrogen? | Answered — strongly. See below. |
| Over what timescale does unopposed-estrogen risk accumulate? | Answered. One to three years, dose- and duration-dependent (Cochrane, via BMS). |
| What is the numerical risk from one missed dose? | Not answered by any study we found. |
| What do official instructions say to do about one miss? | Answered. Product-specific take-or-skip. Never double. |
The number that gives you scale
Prometrium's FDA label contains its own pivotal trial: 358 postmenopausal women, three years, three groups.
| Group | Endometrial hyperplasia over 36 months |
|---|---|
| Estrogen + Prometrium (200 mg, cyclical, 12 days/cycle) | 6% |
| Estrogen alone | 64% |
| Placebo | 3% |
That middle row — 64% — is what three years of estrogen with no progesterone at all did. Not a missed Tuesday — three years of nothing. This comparison is between prescribed regimens over three years. It cannot tell you what one missed dose costs. But it tells you what scale the evidence operates on: years.
The PEPI trial found the same shape: hyperplasia in 20% of women after one year of fully unopposed estrogen, and 62% after three years. One night is not one year. That's not a promise that a missed dose is free — it's the difference between the thing you're picturing and the thing that's actually been studied.
If hyperplasia is ever diagnosed, here's what usually happens
This is the context nobody gives you. For endometrial hyperplasia without atypia — the common kind — RCOG reports:
- ✓Fewer than 5 in 100 progress to endometrial cancer over 20 years
- ✓About 7 to 8 in 10 resolve without any treatment
- ✓About 9 in 10 resolve with progesterone treatment
Read the boundary on that carefully: those figures describe women who already have biopsy-confirmed hyperplasia and are being followed clinically. They do not measure the effect of a missed HRT dose. Hyperplasia with atypia is a different conversation with different management.
You're not the only one frightened. The 2026 BMS guideline reports a 43% increase over three years in urgent suspected-cancer referrals for unscheduled bleeding on HRT, while cancers diagnosed rose 2%over the same period. Those are population-level service figures — referral volumes and diagnosis volumes moving at very different rates. They don't tell you that any individual episode is harmless, and they don't say what share of referred women had cancer. What they do show is that a lot of worry is moving through the system right now, and the cancer numbers aren't moving with it.
Here's where we have to be straight with you
We can't tell you what to do. We don't know your product, your regimen, your estrogen dose, your history, or whether you have a uterus. Any page that hands you one confident universal rule for a missed progesterone dose is overreaching — and some of them contradict each other.
But because we're not inventing a number, we can do the thing they can't: show you the actual current instruction for your actual product, tell you exactly what the evidence does and doesn't establish, and point you at the right question. Then you decide — with your prescriber, not with us.
What is the missed-dose rule for Prometrium, Bijuva, Prempro, and Utrogestan?
The rules differ by product and by market, and the reference points aren't even the same. Bijuva's FDA label uses a two-hour window before the next evening dose. UK combined-HRT guidance uses twelve hours until the next dose. MedlinePlus uses “almost time,” with no number. Prometrium's FDA label, revised February 2026, contains no missed-dose instruction at all.
These are the products we checked. This is not every menopause-HRT product sold in the US or UK. Sources last opened .
| Product | What it is | Market | Source type | Missed-dose instruction | Number? Measured how? | Food / timing |
|---|---|---|---|---|---|---|
| Prometrium | Micronized progesterone 100/200 mg capsule | US | FDA-approved product labeling (rev. 02/2026) | None. The label is silent — no missed-dose section in prescribing information or patient leaflet. | — | Single daily dose at bedtime; food increases absorption |
| Oral progesterone (incl. Prometrium) | Micronized progesterone | US | US government drug monograph — MedlinePlus (rev. 04/15/2026) | Take when you remember. If it's “almost time” for the next dose, skip it. Do not double. | No number. “Almost time.” | Evening or at bedtime |
| Bijuva | Estradiol + progesterone 100 mg capsule, daily | US | FDA-approved product labeling | Take with food as soon as you can — unless within 2 hours of the next evening dose. | 2 hours. Measured until the next dose. | With food. High-fat meal raised progesterone Cmax 162% and AUC 79% |
| Prempro / Premphase | Conjugated estrogens + MPA tablet | US | FDA-approved patient labeling | Take as soon as possible. If it's almost time for the next dose, skip it. Don't take two at the same time. | No number. “Almost time.” | — |
| Angeliq | Estradiol + drospirenone tablet | US | FDA-approved patient labeling | Take as soon as possible — but not if more than 24 hours have passed. | 24 hours. Measured since the missed dose. | — |
| Combined HRT tablets | Estradiol + a progestogen | UK | NHS guidance (health service, not UK regulator) | Take when you remember unless it's less than 12 hours until your next dose. Then skip. Don't double. | 12 hours. Measured until the next dose. | Check your packet |
| Utrogestan | Micronized progesterone (not US-licensed) | UK | UK patient information leaflet | Take when you remember unless it's “nearly time” for the next dose. Never double. | No number. “Nearly time.” | At least 2 hours after food |
| 52 mg levonorgestrel IUD | Levonorgestrel device | US / UK | Professional-society guidance (BMS) | No daily dose to miss. | — | — |
| Compounded progesterone | Pharmacy-mixed | US | No FDA-approved product label exists | Follow your dispensing label. Ask the pharmacy that made it. | — | Preparation-specific |
Read that table again, because there are four different answers in it
And they're not even measuring the same thing. Bijuva's two hours counts forward to your next dose. Angeliq's 24 hours counts backward from the one you missed. Those aren't points on one scale — they're different questions.
A universal cutoff that isn't tied to a named product, a market, and a reference point isn't supported by any source we checked. That's the whole finding.
One more thing the table shows: the food instructions genuinely conflict
Bijuva: take it with food. | UK Utrogestan: at least two hours after food.
Same hormone. Opposite instructions. Neither is wrong — they're different finished formulations designed and tested differently. If you've absorbed one of those rules from the internet and you're taking the other product, you've been following advice that was never about your medication.
So where did the “12-hour rule” come from?
It's real. It's NHS guidance for combined HRT tablets— the ones with both hormones in a single pill. It was never a rule for standalone progesterone capsules, and it doesn't appear in the US labeling we checked. It got picked up, stripped of its context, and applied to everything. That's how an American woman on Prometrium ends up following a rule written for a British woman on a combined tablet. Your product has its own answer. That's the point.
Can I just take two to catch up?
No — not unless your own prescriber has given you a written plan that says so.
MedlinePlus, the Prempro/Premphase patient labeling, UK Utrogestan guidance, and NHS combined-HRT guidance all say not to double. Oral progesterone can cause dizziness and drowsiness, and Prometrium's current label warns that some women experience blurred vision, difficulty speaking, and difficulty walking.
This is the one point where every single source we checked lines up. That basically never happens. Take it seriously.
Some people online will tell you to double up. One page currently circulating tells readers to take two in the same day. That conflicts with the patient labeling for these drugs. What doubling realistically does is make you sedated tomorrow. Prometrium's label documents that during initial therapy, some women get “extreme dizziness and/or drowsiness, blurred vision, slurred speech, difficulty walking.” That's not a trivial trade for a dose you've already missed.
Resume according to your product's instruction. Move on.
Can I take my progesterone in the morning instead of at night?
Only if your product's missed-dose instruction allows it. Prometrium's current FDA label directs a single daily dose at bedtime, and MedlinePlus frames bedtime conditionally: “If progesterone does make you dizzy or drowsy, take your daily dose at bedtime.” Oral progesterone can affect driving and alertness, so the practical question is what you're doing today.
In Prometrium's FDA label, the bedtime instruction sits under Precautions → Dizziness and Drowsiness. MedlinePlus states it as an if-then: ifit makes you dizzy or drowsy, take it at bedtime. That's a tolerability instruction — it's in the section about not falling over.
Knowing whythe bedtime rule exists changes the question you're actually asking. It's less “have I broken something?” and more “am I driving today?”
Getting back on schedule
After a late dose, follow your product's instruction or ask your pharmacist. Don't place two doses close togetherunless your own prescriber has given you that plan. And if you find yourself constantly negotiating with the clock, that's not a you problem — that's a regimen that doesn't fit your life. There's a section on that below.
How many progesterone doses can I actually miss?
No study we found establishes a safe number of missed doses. The British Menopause Society's 10-day and 12-to-14-day figures describe prescribed monthly exposure patterns, not a per-cycle missed-dose allowance. Handle one miss according to your product's instruction, and contact a pharmacist or prescriber after multiple misses or a missed phase.
What the BMS actually says
BMS Tool for Clinicians on progestogens and endometrial protection — reviewed February 2026, published May 2026:
- Women on sequential HRT taking fewer than 10 days of progestogen each month are at increased risk of hyperplasia and endometrial cancer.
- Progestogen at the recommended dose for 12 to 14 days a month does not appear to carry a significant increase in risk for up to five years.
Here's the part where we don't do what you want us to do
You want us to subtract. Twelve days minus one miss equals eleven, eleven is above ten, therefore you're fine. We know you want that. We wanted to give it to you.
But that guidance describes regimens that habitually deliver fewer than 10 days — a prescribing pattern, month after month. It was not written about a single cycle where you missed two doses. Nobody has studied that. Turning it into a green light would be inventing a safety verdict out of a number that was never measuring your situation. So: that's the landscape, not your answer.
Regimen type matters.BMS reports more effective long-term endometrial protection with continuous combined HRT than with sequential HRT. That's a finding about long-term regimens — it doesn't establish a safe number of missed doses in either.
Estrogen dose matters. BMS says progestogen dosing should be proportionate to the estrogen dose, and that evidence on optimal protection with high-dose estrogen remains limited. If you're on a high estrogen dose and missing progesterone doses repeatedly, that combination deserves prescriber review.
I missed a dose and now I'm spotting. Is that connected?
A missed dose can be followed by spotting — NHS guidance says you may have some bleeding or spotting after a missed combined-HRT dose. But the missed dose can't be assumed to be the cause. Don't stop or alter your regimen on your own; follow your product's instruction and report the bleeding.
The most important sentence on this page
Do not stop or change either hormone on your own because you're bleeding.
Your instinct will be to stop the progesterone. The bleeding feels like the medication's fault, so stopping feels like the fix. It's backwards. If you have a uterus and you're taking estrogen, stopping the progesterone removes the thing that opposes it. Follow your product's instruction. Report the bleeding. Those two things go together.
When bleeding needs attention — the UK pathway
From the BMS joint guideline (May 2026), with BSGE, BGCS, FSRH, GIRFT, RCGP and RCOG. This is UK guidance and these are clinician imaging thresholds, not self-triage rules.
- UrgentTransvaginal ultrasound within six weeks if first bleeding occurs more than six months after starting HRT, or more than three months after a dose or preparation change
- UrgentUltrasound within six weeks at any time for prolonged or heavy bleeding, or when two minor endometrial-cancer risk factors are present
- Cancer referralUrgent suspected-cancer referral for one major or three minor risk factors
- Low riskFully visualized endometrium 4 mm or less on continuous combined HRT, or 7 mm or less on sequential HRT
Risk factors: BMI 40+, or Lynch or Cowden syndrome = major. BMI 30–39, diabetes, or PCOS = minor.
The fear you haven't said out loud
You're not really afraid of the spotting. You're afraid that if you tell your doctor, they'll take your HRT away.
A missed dose or an episode of bleeding does not automatically end HRT.The 2026 BMS pathway includes a range of next steps: an adherence check, a progestogen adjustment, imaging, temporary cessation, weaning, or a different treatment plan. “Adjust the progestogen” is genuinely on that list. So tell them what happened. Hiding it is the only move that reliably makes things worse.
Get help now — not later — if:
- ⚠Bleeding is heavy, or comes with faintness, weakness, or severe pain
- ⚠Bleeding after sex
- ⚠New pelvic pain
- ⚠Any bleeding that feels genuinely wrong to you
What if I missed two or more — or I can't remember if I took it?
Don't stack doses to make up for several misses, and don't take an extra one to resolve uncertainty. Contact a pharmacist or prescriber — the right answer depends on your product, how many you missed, whether your estrogen continued, and whether your regimen is daily or cyclical.
“I missed two or more”
Contact your pharmacist or prescriber. Urgency goes up if you're bleeding. Have this ready:
- Exact product and strength
- Route and market
- Daily or cyclical (and which days)
- Last dose you're certain you took
- How many you missed
- Whether your estrogen continued
- Any bleeding or symptoms
- When your next dose is due
“I can't remember if I took it”
Incredibly common. Don't take an extra dose just to settle it. That turns a maybe into a definite double.
Check your blister pack, pill organizer, medication log, or pharmacy app. Count what's left against the date. That resolves it most of the time. If it still doesn't, follow your current packet's instruction or ask a pharmacist — that's precisely what they're for, and you don't need an appointment.
Then fix the system. If you can't remember, the issue isn't your memory. It's that nothing is recording the answer for you.
“I missed my whole progesterone phase this month”
More common than you'd think. Missing an entire progesterone phase is a reason to contact your prescriber promptly.Not tomorrow-morning-panic. But don't quietly wait for the next cycle and hope.
Whether imaging is needed depends on bleeding, your regimen, how long you were underexposed, and your individual risk factors. Your prescriber may want to do something with this cycle rather than skip it — that's their call, and they can only make it if they know. Send the message instead.
Should I keep taking my estrogen?
Don't independently stop, increase, or rearrange either hormone. Follow the missed-dose instruction for your exact product. Contact your prescriber after repeated misses, a missed phase, or any uncertainty about whether your estrogen should continue.
The one boxed warning the FDA kept
In November 2025, the FDA initiated removal of boxed-warning language on menopausal hormone therapy. On February 12, 2026, it approved updated labeling for the first six products. Prometrium was one of them — along with Divigel, Cenestin, Enjuvia, Estring, and Bijuva.
What changed: statements about cardiovascular disease, breast cancer, and probable dementia were removed from the boxed warningfor those products. Note that precisely — removed from the box. Cardiovascular and breast cancer information remains elsewhere in systemic-product labeling. This isn't the class being declared safe; it's the most prominent warning being narrowed.
And the FDA retained one boxed warning: endometrial cancer, on systemic estrogen-alone products used by women with a uterus.After a comprehensive review of decades of evidence, the agency moved most of the alarming language out of the most prominent box. The one it kept in the box is the one your progesterone exists to prevent. Your medication isn't the danger. Estrogen running long-term without adequate progestogen cover is the thing the warning is about.
If your regimen keeps losing to your actual life, that's fixable
Find My HRT Path
Takes about 90 seconds. It organizes your symptoms, state, route preferences, and care constraints into a provider-model shortlist and a set of questions to bring to a clinician. It doesn't choose a prescription or a dose — it makes sure you walk in with the right question.
Find My HRT Path →About 90 seconds. Find My HRT Path may route to providers we have affiliate relationships with.
Does this page apply to me? The exceptions
No, if you take progesterone for fertility treatment, pregnancy support, contraception, or gender-affirming care. Those use different products on different schedules for different reasons, and a menopause missed-dose rule should never be transferred to them. “Progesterone” is doing an enormous amount of work in medicine.
| Your situation | Does this page apply? | Who to ask instead |
|---|---|---|
| Menopause or perimenopause HRT | Yes | Your prescriber or pharmacist |
| IVF, fertility, pregnancy support | No | Your fertility or obstetric clinic — use its protocol |
| Progestin-only contraception | No | Your product's own missed-pill instructions |
| Gender-affirming hormone therapy | No | Your prescriber |
| Compounded progesterone | Partly — no FDA-approved label exists | The pharmacy that dispensed it |
| 52 mg levonorgestrel IUD | No daily dose to miss | Confirm device and insertion date |
| Lower-dose IUD (13.5 / 19.5 mg) | Ask — may need added progestogen | Your prescriber |
| Vaginal progesterone | Partly — regimen-specific, off-label in the US | Your prescriber |
Menopause HRT is not contraception. UK guidance advises contraception for two yearsafter your last natural period if you're under 50, or one yearif you're 50 or older. If pregnancy is still possible for you, that's a separate plan.
If your progesterone is compounded
A compounded preparation doesn't have a single FDA-approved product label, so there's no official missed-dose rule to look up.Its formulation and instructions are preparation-specific. Follow your dispensing label and ask the pharmacy that made it. Don't borrow Prometrium's or Bijuva's instructions — those belong to different products.
The BMS position (reviewed February 2026, published May 2026) is direct: micronized progesterone has variable absorption through the skin and should not be given transdermally within HRT, because it's unlikely to provide sufficient endometrial protection. The Society also raises concerns about the purity, potency, and safety of compounded preparations, and notes a lack of evidence that the progesterone doses used in them protect the endometrium adequately. Its conclusion: the use of compounded products is not recommended.
If a compounded cream is your only progesterone, you have a uterus, and you're taking estrogen — that's worth a conversation with a clinician regardless of any missed dose. See our compounded vs FDA-approved HRT guide for more.
When should I get help right now?
Emergency symptoms aren't a missed-dose question and shouldn't be worked out from an article. Call 911 for collapse, seizure, trouble breathing, inability to wake someone, chest pain, or sudden weakness or trouble speaking. In the US, contact Poison Control at 1-800-222-1222 for an accidental extra dose or an unknown amount.
⚷ Call 911 now
- Collapse or seizure
- Trouble breathing
- Can't be woken
- Sudden weakness, facial droop, trouble speaking, vision changes
- Chest pain or sudden shortness of breath
- Severe allergic reaction — swelling of face, throat, or tongue; hives with trouble breathing
Prometrium's current US label lists peanut oil — check ingredient list for your exact brand or generic.
Poison Control
1-800-222-1222
For an accidental extra dose, or if you don't know how much was taken. Product- and amount-specific advice. US only. Also at poison.org. They'd rather hear from you.
Contact prescriber soon
- Two or more missed doses
- Missing doses repeatedly
- A missed progesterone phase
- New bleeding after menopause, or bleeding that keeps returning
- Missed doses while on a high estrogen dose
Why do I keep missing progesterone? And how do I stop?
If misses keep happening, treat the regimen and the reminder system as the problem to solve — not as a character flaw. Day-counting is harder to sustain than a daily habit, and clinicians have real alternatives: a different schedule, a combination capsule, or a levonorgestrel IUD that removes the daily decision entirely.
Let's kill the guilt first
An NHS clinical presentation on progestogen prescribing lists, on a slide for an audience of doctors: “some women forget their progestogen.” It sits alongside supply shortages and prescribing errors. Missing progestogen is a known treatment-adherence problem, not a personal failure. That's not a consolation prize. It's permission to stop blaming yourself and start fixing the setup.
Why cyclical is genuinely harder
Daily is a habit. Cyclical is arithmetic — every single month. You have to know what cycle day it is. Remember it starts on day 15. Remember it stops on day 26. Forever. While perimenopause is actively degrading your sleep and your concentration.
BMS lists days 1–12 of each calendar month as a practical scheduling option for an appropriate sequential regimen — the date does the counting instead of you. Any schedule change has to be made with your prescriber. But most women have never heard the option exists.
| Option | What changes | Who it suits |
|---|---|---|
| Calendar-month dosing (days 1–12) | Still cyclical — but the calendar counts, not you | Women who want to stay sequential |
| Continuous daily | No day-counting. Same pill, every night. | Postmenopausal women who don't want a monthly bleed |
| Combination capsule | One pill, both hormones. Can't miss one without the other. | Women juggling two prescriptions |
| 52 mg levonorgestrel IUD | No daily dose to miss for the supported in-use period | Women who are done with the daily decision |
One thing not to do: don't quietly reduce your own progesterone.
That same NHS presentation flags this as an active problem — women reducing or skipping progestogen on purpose because of side effects, sometimes encouraged by social media, and sometimes wrongly advised by clinicians. If progesterone makes you feel awful, that's a real problem with real answers: a different type, a different route, different timing, an IUD. Silently taking less isn't one of them. Say it out loud instead. There's usually a fix.
Bigger question: does your regimen fit your life?
Find My HRT Path
You've now got the two things worth bringing to a clinician: your product's actual instruction, and an honest picture of what's known. If what's left is whether your route, regimen, or provider fits your life — that's what this is for. About 90 seconds. Flags when online care isn't the right starting point.
Find My HRT Path →The HRT Index may earn a commission if you choose a provider through our links. That doesn't change what you pay, or the criteria we use. Affiliate disclosure.
What women actually ask after missing progesterone
Real questions, in their own words. We're including these so you know you're not alone — not as evidence of anything medical.
“Could this be the cause of my bad day?” — r/Menopause
“Is it best to take it as soon as you can, or just skip it?” — r/Menopause
“I've not taken any of those and it's now day 27.” — Mumsnet
These excerpts show what women ask. They are not medical evidence, and other people's dosing suggestions don't replace your product's instructions.
What we actually verified
On , we opened the source documents listed below and checked each one for missed-dose wording, numerical cutoffs, the reference point being measured, food and timing instructions, market, and revision date.
What we checked
- Prometrium — FDA-approved labeling, rev. 02/2026: prescribing info and patient leaflet
- Bijuva — FDA-approved labeling via DailyMed
- Prempro / Premphase — FDA-approved patient labeling
- Angeliq — FDA-approved patient labeling
- MedlinePlus progesterone monograph (NIH/NLM), rev. 04/15/2026
- Utrogestan — UK patient information leaflet and NHS medicines pages
- NHS guidance for continuous and sequential combined HRT
- BMS — Tool for Clinicians on progestogens and endometrial protection (reviewed Feb 2026, published May 2026)
- BMS joint guideline on management of unscheduled bleeding on HRT (May 2026)
What surprised us
Prometrium's current FDA label — for the most-prescribed standalone progesterone in America — contains no missed-dose instruction at all. Not in the prescribing information, not in the patient leaflet. That null result is the reason the advice you find online is invented.
What we did not do
We did not take these medications, test any pharmacy's support line, consult any provider, or assess anyone's individual prescription. We are not clinicians and this page was not medically reviewed by one.
What we did not check:this is not every menopause-HRT product sold in the US or UK. If your product isn't in our table, that's a gap in our coverage — not a sign the answer doesn't exist. Ask your pharmacist.
Found something that's changed?Send us the product, the country, and the current packet or source. We'll check it and update the date.
Last updated: · Last verified:
Frequently asked questions
The full answers are in the sections above. These short versions are for quick reference.
- Can I take two progesterone capsules tonight if I missed one?
- No — not unless your own prescriber has given you a written plan that says so. MedlinePlus, the Prempro/Premphase patient labeling, UK Utrogestan guidance, and NHS combined-HRT guidance all say not to double.
- Can I take last night's progesterone this morning?
- Only if your product's missed-dose instruction allows it. Prometrium's label directs bedtime dosing, and MedlinePlus frames bedtime as a response to drowsiness. Oral progesterone can affect driving and alertness, so factor in your day.
- How late is too late?
- There's no universal answer — that's the finding. Bijuva says within two hours of the next dose (forward). Angeliq says not after 24 hours have passed (backward). NHS combined-HRT guidance says less than 12 hours until the next dose. MedlinePlus says only “almost time.” Different products, different reference points. Find yours in the audit table above.
- Will one missed dose cause cancer?
- No evidence we reviewed shows that one missed dose causes cancer — but the available trials don't measure one-dose risk. The 6% versus 64% Prometrium-label result compared a prescribed 12-days-per-cycle regimen against up to three years of estrogen alone. It can't prove that one missed dose changes risk by zero.
- Will I have to stop HRT because I missed doses?
- A missed dose or an episode of bleeding does not automatically end HRT. The 2026 BMS pathway includes adherence review, progestogen adjustment, imaging, temporary cessation, or a different plan, depending on your bleeding pattern and risk factors. Tell your prescriber rather than stopping on your own.
- Should I get an ultrasound because I missed a dose?
- That depends on bleeding, your regimen, how long you were underexposed, and your risk factors. This page can't rule it in or out. The UK thresholds in the bleeding section show what your clinician will be weighing.
- Is progesterone the same as a progestin?
- Micronized progesterone (Prometrium, Bijuva) is chemically identical to what your ovaries make. Progestins like medroxyprogesterone (Provera, Prempro) and norethindrone are synthetic. Different products, different labels, different missed-dose instructions. BMS reports micronized progesterone and medroxyprogesterone as equivalent for endometrial protection — but they are not the same drug.
- I have a Mirena — do I need progesterone too?
- If it's the 52 mg levonorgestrel IUD, it provides the progestogen component and there's no daily dose to miss. In the US it isn't FDA-approved for that specific use, though BMS guidance supports it for up to five years. Lower-dose IUDs (13.5 mg, 19.5 mg) are different — added progestogen is likely needed. Confirm which device you have and when it was inserted.
- I've had a hysterectomy — do I need progesterone at all?
- Endometrial protection is the main reason it's prescribed, but progesterone is sometimes prescribed for other reasons. Don't stop based on a webpage. Ask why it's in your regimen. See our HRT after hysterectomy guide.
- Can I take progesterone with food?
- Depends on your product, and the instructions genuinely differ. Bijuva: with food. UK Utrogestan: at least two hours after food. Prometrium's label doesn't instruct either way but notes food increases absorption. Follow the product you were dispensed.
- What if I vomited after taking it?
- Don't automatically repeat the dose. Call your pharmacist — absorption depends on the product and how much time had passed.
- My HRT patch fell off, or I missed a change. Same rules?
- No. Patch instructions are product-specific and don't follow oral-progesterone rules. Check your exact brand's replacement instruction or ask your pharmacist.
- I use compounded progesterone cream. Does this page apply?
- Not directly — there's no FDA-approved label to consult. Ask the pharmacy that dispensed it. And read the compounded section above: BMS does not recommend transdermal progesterone for endometrial protection.
What to do next
- 1Find your exact product and market. Bottle, pharmacy app, or portal. Two minutes.
- 2Follow its current take-or-skip instruction. Don't double unless your own clinician gave you that plan.
- 3Send the message if you missed several doses, missed a phase, still aren't sure, or have concerning bleeding.
You missed a dose. That's all that's happened so far. Use the instruction for your exact product. Don't double. Get product-specific help if you missed several, or if you're bleeding in a way that worries you. Once you've done that and none of the escalation conditions apply, you're done — and you're allowed to stop trying to solve this from generic internet advice at midnight.
Go to sleep.
Still not sure which HRT program is right for you?
Take our free 90-second matching quiz.
Find My HRT Path →Sources
FDA-approved product labeling
- •Prometrium (progesterone, USP) capsules, rev. 02/2026 — accessdata.fda.gov
- •Bijuva (estradiol and progesterone) capsules — DailyMed
- •Prempro / Premphase (conjugated estrogens / medroxyprogesterone acetate) — FDA-approved patient labeling
- •Angeliq (estradiol / drospirenone) — FDA-approved patient labeling
US government drug information
- •MedlinePlus (NIH / National Library of Medicine), Progesterone, revised April 15, 2026 — medlineplus.gov
- •Poison Control — poison.org · 1-800-222-1222
FDA regulatory actions
- •FDA, FDA Approves Labeling Changes to Menopausal Hormone Therapy Products, February 12, 2026 — fda.gov
- •FDA / HHS, HHS Advances Women's Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy, November 10, 2025
- •FDA, Menopausal Hormone Therapies with Updated Prescribing Information, updated February 12, 2026 — fda.gov
- •FDA, Compounding and the FDA: Questions and Answers — fda.gov
UK product leaflets and health-service guidance
- •Utrogestan 100 mg capsules — UK patient information leaflet (emc)
- •NHS — Utrogestan; continuous combined HRT; sequential combined HRT medicines pages — nhs.uk
Professional-society guidance
- •British Menopause Society, Tool for Clinicians: Progestogens and Endometrial Protection — reviewed February 2026, published May 2026 — thebms.org.uk
- •BMS / BSGE / BGCS / FSRH / GIRFT / RCGP / RCOG, Management of Unscheduled Bleeding on HRT — May 2026
- •RCOG / BSGE, Management of Endometrial Hyperplasia (Green-top Guideline No. 67) and RCOG patient information
- •The Menopause Society, 2022 Hormone Therapy Position Statement — menopause.org
Peer-reviewed
- •PEPI Trial Writing Group. JAMA 1996;275(5):370–5
- •Furness S, et al. Cochrane Database Syst Rev 2012, CD000402
- •Stute P, et al. Climacteric 2016;19(4):316–28
- •Sriprasert I, et al. (ELITE). Maturitas 2021;154:13–19
Language research only — not medical evidence: r/Menopause; Mumsnet menopause forum